Harrow, Inc. Public Float
Harrow, Inc. (HROW) had Public Float of $1.00 billion as of 2025-06-30, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-02
- 2025-06-30: Entity Public Float $1.00B.
- 2024-06-28: Entity Public Float $678.00M.
- 2023-06-30: Entity Public Float $464.00M.
- 2022-06-30: Entity Public Float $159.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.00B 10-K · filed 2026-03-02 |
| 2024-06-28 | $678.00M 10-K · filed 2025-03-27 |
| 2023-06-30 | $464.00M 10-K · filed 2024-03-19 |
| 2022-06-30 | $159.00M 10-K · filed 2023-03-23 |
| 2021-06-30 | $196.00M 10-K · filed 2022-03-10 |
| 2020-06-30 | $125.00M 10-K · filed 2021-03-08 |
| 2019-06-28 | $205.00M 10-K · filed 2020-03-13 |
| 2018-06-29 | $42.00M 10-K · filed 2019-03-12 |
| 2017-06-30 | $59.00M 10-K · filed 2018-03-08 |
| 2016-06-30 | $45.00M 10-K · filed 2017-03-21 |
| 2015-06-30 | $58.00M 10-K · filed 2016-03-23 |
| 2014-06-30 | $47.00M 10-K · filed 2015-03-12 |
| 2013-06-28 | $57.00M 10-K · filed 2014-03-28 |
| 2012-08-14 | $29.70K 10-Q · filed 2012-08-14 |
| 2012-06-29 | $11.00M 10-K · filed 2013-03-18 |
| 2012-02-23 | $216.38K 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |